Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 18, 2024

Age-Related Disparity in Disease-Modifying Therapy Administration Among Patients With MS

Journal of the Neurological Sciences

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the Neurological Sciences
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry
J. Neurol. Sci. 2024 May 16;461(xx)123052, MA Piedrabuena, J Correale, M Fiol, M Marrodan, JI Rojas, M Alonso, A Pappolla, J Miguez, L Patrucco, E Cristiano, C Vrech, L Cohen, R Alonso, B Silva, G Luetic, N Deri, M Burgos, S Liwacki, R Piedrabuena, V Tkachuk, A Barboza, A Martinez, ME Balbuena, AA Pinheiro, P Nofal, PA Lopez, D Tavolini, F Leguizamon, JP Hryb, S Tizio, L Recchia, E Reich, EC Contentti, MP Marcilla, F Pagani, LM Cabrera, MC Curbelo, C Mainella, NF Liguori, M Coppola, JP Pettinicchi, A Carra, G Jose, D Nadur, S Bestoso, C Pestchanker, GD Vazquez, CM Martinez, MC Ysrraelit

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading